Related Experiment Video
Updated: Jun 26, 2026

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
Published on: May 20, 2020
Functional selectivity of EGF family peptide growth factors: implications for cancer
Kristy J Wilson1, Jennifer L Gilmore, John Foley
1Purdue University School of Pharmacy and Purdue Cancer Research Center, West Lafayette, IN 47907-2064, USA.
Abstract:
Breast, prostate, pancreatic, colorectal, lung, and head and neck cancers exploit deregulated signaling by ErbB family receptors and their ligands, EGF family peptide growth factors. EGF family members that bind the same receptor are able to stimulate divergent biological responses both in cell culture and in vivo. This is analogous to the functional selectivity exhibited by ligands for G-protein coupled receptors. Here we review this literature and propose that this functional selectivity of EGF family members is due to distinctions in the conformation of the liganded receptor and subsequent differences in the sites of receptor tyrosine phosphorylation and receptor coupling to signaling effectors. We also discuss the roles of divergent ligand activity in establishing and maintaining malignant phenotypes. Finally, we discuss the potential of mutant EGF family ligands as cancer chemotherapeutics targeted to ErbB receptors.
Insights
ErbB receptor signaling is altered in many cancers. Different EGF-family ligands binding the same receptor can cause distinct biological effects, influencing cancer development and treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- ErbB receptors and EGF-family ligands are crucial in various cancers.
- Ligand binding to ErbB receptors can elicit diverse biological responses.
- This functional selectivity is comparable to G-protein coupled receptors.
Purpose of the Study:
- To review the literature on functional selectivity of EGF-family ligands.
- To propose mechanisms underlying this selectivity.
- To discuss its implications in cancer and potential therapeutic applications.
Main Methods:
- Literature review and synthesis of existing research.
- Analysis of receptor conformation, phosphorylation, and effector coupling.
- Discussion of ligand activity in malignant phenotypes.
Main Results:
- EGF-family ligands binding the same ErbB receptor can induce distinct signaling outcomes.
- Functional selectivity is attributed to differences in liganded receptor conformation.
- These differences impact receptor tyrosine phosphorylation and effector coupling.
Conclusions:
- Divergent ligand activity plays a role in cancer development and progression.
- Mutant EGF-family ligands show potential as targeted cancer therapeutics for ErbB receptors.
Related Concept Videos
Mitogens and the Cell Cycle
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Regulation of Angiogenesis and Blood Supply
Selectins
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

